Microbiome and Axial Spondyloarthritis
The Role of the Gut Microbiome in Axial Spondyloarthritis (AxSpA) Disease Activity
Sponsor: Spondylitis Association of America (SAA)
Terminated
Sufficient samples and data have been collected for data analyses.
Other Axial Spondyloarthritis trials with similar outcome
Listed as NCT04713995, this NA trial focuses on Axial Spondyloarthritis and remains terminated or withdrawn. Sponsored by Spondylitis Association of America (SAA), it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
May 2022 — Sep 2022 [monthly]
Recruiting NA
-
Nov 2021 — May 2022 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Sep 2021 — Nov 2021 [monthly]
Recruiting NA
-
Jun 2021 — Sep 2021 [monthly]
Recruiting NA
Phase: PHASE2_PHASE3 → NA
-
Feb 2021 — Jun 2021 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Spondylitis Association of America (SAA)
- Viome
For direct contact, visit the study record on ClinicalTrials.gov .